Advertisement

Metal hearts undergo trials

Regulators have given permission for a US biotechnology company to implant metal hearts in a handful of critically ill patients.

By | January 31, 2001

The US Food and Drug Administration has given permission for a US biotechnology company to conduct a unique trial involving the implantation of metal hearts in a handful of critically ill patients.

Massachusetts-based Abiomed has developed the heart, called AbioCor, which is made of titanium and plastic and is about the size of a grapefruit. Abiomed's vice-president of external relations, Ed Berger, said: "As far as we know, it will be the first time an implantable artificial heart has been tried in a clinical study".

Currently in the US, 100,000 critically ill patients would benefit from a heart transplant each year. But only about 2,000 hearts are donated annually for operations. Berger commented: "Hospitals want to use the hearts available as frugally and effectively as possible — which means they tend to be reserved for the healthiest people. People who are older, or have other medical conditions, often lose out."

Although Abiomed has not put an exact price on the hearts, Berger said that the company is aiming to make a transplant with the artificial heart no more expensive than an operation involving a human heart.

Advertisement
Advertisement

Popular Now

  1. Lost Y Chromosome Genes Found on Autosomes
  2. Brain Drain
    Daily News Brain Drain

    The brain contains lymphatic vessels similar to those found elsewhere in the body, a mouse study shows.

  3. Next Generation: Souped-up Probiotics Pinpoint Cancer
  4. Genomes Point the Way
    Daily News Genomes Point the Way

    Sequence analysis of Egyptian, Ethiopian, and non-African peoples indicates a likely route taken by modern humans migrating out of Africa.

Advertisement
Advertisement
Eppendorf
Eppendorf